Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Complete ACA
- Development stage
- Unknown
- Lead developer
- Legacy Medical Consultants
- Modality
- Adoptive Cell Transfer → Cell Therapies, Other Cell Types → Cell Therapies, Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
Complete ACA is a dehydrated, tri-layer human amniotic membrane allograft consisting of amnion, chorion, and a second layer of amnion (ACA). Developed by Legacy Medical Consultants, it is utilized as a biological skin substitute or wound cover for the management of chronic, non-healing wounds, including diabetic foot ulcers (DFU), venous leg ulcers (VLU), and pressure ulcers (PU). The allograft provides a natural extracellular matrix (ECM) scaffold that facilitates cellular attachment and proliferation. It also retains essential endogenous growth factors and cytokines that modulate the inflammatory environment and promote tissue regeneration. Complete ACA is processed to maintain the structural integrity of the tissue while ensuring safety and sterility for clinical application in wound care centers.
- Brand names
- Complete ACA
- Other names
- Complete Amnion-Chorion-Amnion Allograft
Beyond the preview
Go deeper on Complete ACA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Complete ACA.